VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. van 't Veer on Guidelines for Genetic Testing in Breast Cancer

Laura van 't Veer, PhD
Published: Friday, Oct 27, 2017



Laura van ’t Veer, PhD, Leader of the Breast Oncology Program, and director of Applied Genomics, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the guidelines for genetic testing in breast cancer.

For women who are diagnosed with breast cancer and have a family history, the guidelines for genetic testing are quite clear. But information of genetic risk is relevant for every woman, regardless of family history, states van ‘t Veer.

Nowadays, physicians can look at the genetics of a given patient for a risk score to advise screening decisions.
 


Laura van ’t Veer, PhD, Leader of the Breast Oncology Program, and director of Applied Genomics, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the guidelines for genetic testing in breast cancer.

For women who are diagnosed with breast cancer and have a family history, the guidelines for genetic testing are quite clear. But information of genetic risk is relevant for every woman, regardless of family history, states van ‘t Veer.

Nowadays, physicians can look at the genetics of a given patient for a risk score to advise screening decisions.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x